Clinical Trial

Evaluation of a Nigella Sativa Extract (10% Thymoquinone, Nisatol®) in Perimenopausal Women With Metabolic Syndrome

Completed
View on ClinicalTrials.gov →
Summary
A prospective, multicenter, randomized controlled study evaluating the efficacy and safety of a Nigella sativa extract standardized to 10% thymoquinone (Nisatol®) in perimenopausal women with metabolic syndrome. The study will assess changes in metabolic and blood pressure parameters, as well as improvements in menopausal symptoms and quality of life.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-05.
Status change: Not Yet Recruiting → Completed 2025-12-22
Trial Details
NCT Number NCT07013058
Lead Sponsor Liaquat University of Medical & Health Sciences
Collaborators: University of Urbino "Carlo Bo"
Conditions Metabolic Syndrome, Elevated Blood Pressure
Enrollment 50 participants
Start Date 2025-06-15
Primary Completion 2025-11-30 (estimated)
Study Completion 2025-12-19 (estimated)
Updated on ClinicalTrials.gov 2025-12-30